Articles with public access mandates - Cheng-Teng IpLearn more
Not available anywhere: 3
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
CT Ip, S Olbrich, M Ganz, B Ozenne, K Köhler-Forsberg, VH Dam, ...
European Neuropsychopharmacology 49, 101-112, 2021
Mandates: Innovation Fund Denmark
Different underlying mechanisms for face emotion and gender processing during feature-selective attention: Evidence from event-related potential studies
H Wang, C Ip, S Fu, P Sun
Neuropsychologia 99, 306-313, 2017
Mandates: National Natural Science Foundation of China
Relative expertise affects N170 during selective attention to superimposed face‐character images
C Ip, H Wang, S Fu
Psychophysiology 54 (7), 955-968, 2017
Mandates: National Natural Science Foundation of China
Available somewhere: 10
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A …
K Köhler-Forsberg, A Jorgensen, VH Dam, DS Stenbæk, PM Fisher, CT Ip, ...
Frontiers in psychiatry 11, 641, 2020
Mandates: Danish Council for Independent Research, Innovation Fund Denmark
Pre-intervention test-retest reliability of EEG and ERP over four recording intervals
CT Ip, M Ganz, B Ozenne, LB Sluth, M Gram, G Viardot, P l'Hostis, ...
International Journal of Psychophysiology 134, 30-43, 2018
Mandates: Innovation Fund Denmark
Configural and featural face processing are differently modulated by attentional resources at early stages: an event-related potential study with rapid serial visual presentation
H Wang, P Sun, C Ip, X Zhao, S Fu
Brain research 1602, 75-84, 2015
Mandates: National Natural Science Foundation of China
Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
VH Dam, DS Stenbæk, K Köhler-Forsberg, C Ip, B Ozenne, BJ Sahakian, ...
Psychological medicine 51 (14), 2347-2356, 2021
Mandates: Innovation Fund Denmark
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
CT Ip, M Ganz, VH Dam, B Ozenne, A Rüesch, K Köhler-Forsberg, ...
Journal of psychiatric research 141, 57-65, 2021
Mandates: Innovation Fund Denmark
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction
K Köhler-Forsberg, VH Dam, B Ozenne, A Sankar, V Beliveau, ...
JAMA psychiatry 80 (4), 296-304, 2023
Mandates: Danish Council for Independent Research, Innovation Fund Denmark
Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
VH Dam, DS Stenbæk, K Köhler-Forsberg, C Ip, B Ozenne, BJ Sahakian, ...
Translational psychiatry 12 (1), 468, 2022
Mandates: Innovation Fund Denmark
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
K Köhler-Forsberg, B Ozenne, SV Larsen, AS Poulsen, EB Landman, ...
Translational psychiatry 12 (1), 273, 2022
Mandates: Danish Council for Independent Research, Innovation Fund Denmark
Evidence for a serotonergic subtype of major depressive disorder: A NeuroPharm-1 study
K Köhler-Forsberg, B Ozenne, EB Landman, SV Larsen, AS Poulsen, ...
medRxiv, 2021.06. 17.21258740, 2021
Mandates: Danish Council for Independent Research, Innovation Fund Denmark
Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression
CT Ip, M Ganz, B Ozenne, S Olbrich, V Beliveau, VH Dam, ...
European Neuropsychopharmacology 70, 32-44, 2023
Mandates: Innovation Fund Denmark
Publication and funding information is determined automatically by a computer program